Condition: Perioperative Myocardial Injury · Autonomic Dysfunction · Cardiovascular (CV) Risk · Sponsor: Insel Gruppe AG, University Hospital Bern
Limiting perioperative tachycardia (aiming for a heart rate \<90 beats per minute throughout the perioperative period) using the ultra-short acting beta-blocker landiolol in patients with cardiovascular risk factors undergoing major surgery might lower the incidence of perioperative myocardial injury. Feasibility of the intervention needs to be proven prior to conduction of a larger trial.
This description comes directly from the study's public registry record.
Christian M Beilstein, MD · +41316644308 · christian.beilstein@insel.ch
Patrick Y Wuethrich, Prof MD · +41316322483 · patrick.wuethrich@insel.ch
Always discuss trial participation with your own doctor first.
| Bern University Hospital, Freiburgstrasse | Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07168421